These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 29337030

  • 1. Nasal IL-25 predicts the response to oral corticosteroids in chronic rhinosinusitis with nasal polyps.
    Hong H, Chen F, Sun Y, Yang Q, Gao W, Cao Y, Fan Y, Shi J, Li H.
    J Allergy Clin Immunol; 2018 May; 141(5):1890-1892. PubMed ID: 29337030
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nasal expression of the vascular endothelial growth factor and its receptors is reduced by mepolizumab in chronic rhinosinusitis with nasal polyposis.
    Cavaliere C, Masieri S, Greco A, Lambiase A, Segatto M.
    Ann Allergy Asthma Immunol; 2021 Apr; 126(4):442-443. PubMed ID: 33465456
    [No Abstract] [Full Text] [Related]

  • 5. Do preoperative corticosteroids benefit patients with chronic rhinosinusitis with nasal polyposis?
    Carlton DA, Chiu AG.
    Laryngoscope; 2019 Apr; 129(4):773-774. PubMed ID: 30408190
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Monoclonal Antibodies for the Treatment of Nasal Polyps.
    Willson TJ, Naclerio RM, Lee SE.
    Immunol Allergy Clin North Am; 2017 May; 37(2):357-367. PubMed ID: 28366482
    [Abstract] [Full Text] [Related]

  • 9. Oral corticosteroids in the management of chronic rhinosinusitis with and without nasal polyps: Risks and benefits.
    Poetker DM.
    Am J Rhinol Allergy; 2015 May; 29(5):339-42. PubMed ID: 26358344
    [Abstract] [Full Text] [Related]

  • 10. The influence of inhibitors of apoptosis proteins (IAPs) on chronic rhinosinusitis with nasal polyps.
    Passos IM, Tamashiro E, Fantucci MZ, Murashima AAB, Silva LECM, Garcia DM, Faria FM, Martins RB, Arruda E, Anselmo-Lima WT, Valera FCP.
    Rhinology; 2024 Feb 01; 62(1):101-110. PubMed ID: 37864409
    [Abstract] [Full Text] [Related]

  • 11. Role of steroids in the treatment of rhinosinusitis with and without polyposis.
    Fokkens W.
    Clin Allergy Immunol; 2007 Feb 01; 20():241-50. PubMed ID: 17534055
    [No Abstract] [Full Text] [Related]

  • 12. Effects of Fluticasone Furoate Nasal Spray on Parameters of Eosinophilic Inflammation in Patients With Nasal Polyposis and Perennial Allergic Rhinitis.
    Špadijer Mirković C, Perić A, Vukomanović Đurđević B, Vojvodić D.
    Ann Otol Rhinol Laryngol; 2017 Aug 01; 126(8):573-580. PubMed ID: 28587510
    [Abstract] [Full Text] [Related]

  • 13. Mucin 1 downregulation associates with corticosteroid resistance in chronic rhinosinusitis with nasal polyps.
    Milara J, Peiró T, Armengot M, Frias S, Morell A, Serrano A, Cortijo J.
    J Allergy Clin Immunol; 2015 Feb 01; 135(2):470-6. PubMed ID: 25159466
    [Abstract] [Full Text] [Related]

  • 14. Effects of Fluticasone Furoate on Clinical and Immunological Outcomes (IL-17) for Patients With Nasal Polyposis Naive to Steroid Treatment.
    Venkatesan N, Lavigne P, Lavigne F, Hamid Q.
    Ann Otol Rhinol Laryngol; 2016 Mar 01; 125(3):213-8. PubMed ID: 26405064
    [Abstract] [Full Text] [Related]

  • 15. Oral corticosteroids in the management of adult chronic rhinosinusitis with and without nasal polyps: an evidence-based review with recommendations.
    Poetker DM, Jakubowski LA, Lal D, Hwang PH, Wright ED, Smith TL.
    Int Forum Allergy Rhinol; 2013 Feb 01; 3(2):104-20. PubMed ID: 22887970
    [Abstract] [Full Text] [Related]

  • 16. Role of interleukin-17A in the eosinophil accumulation and mucosal remodeling in chronic rhinosinusitis with nasal polyps associated with asthma.
    Saitoh T, Kusunoki T, Yao T, Kawano K, Kojima Y, Miyahara K, Onoda J, Yokoi H, Ikeda K.
    Int Arch Allergy Immunol; 2010 Feb 01; 151(1):8-16. PubMed ID: 19672092
    [Abstract] [Full Text] [Related]

  • 17. Corticosteroid treatment in chronic rhinosinusitis: the possibilities and the limits.
    Mullol J, Obando A, Pujols L, Alobid I.
    Immunol Allergy Clin North Am; 2009 Nov 01; 29(4):657-68. PubMed ID: 19879441
    [Abstract] [Full Text] [Related]

  • 18. Charcot-Leyden crystal concentration in nasal secretions predicts clinical response to glucocorticoids in patients with chronic rhinosinusitis with nasal polyps.
    Wu D, Yan B, Wang Y, Zhang L, Wang C.
    J Allergy Clin Immunol; 2019 Jul 01; 144(1):345-348.e8. PubMed ID: 31002832
    [No Abstract] [Full Text] [Related]

  • 19. Expression of leukotriene and its receptors in eosinophilic chronic rhinosinusitis with nasal polyps.
    Wu X, Hong H, Zuo K, Han M, Li J, Wen W, Xu G, Miao B, Li H.
    Int Forum Allergy Rhinol; 2016 Jan 01; 6(1):75-81. PubMed ID: 26332237
    [Abstract] [Full Text] [Related]

  • 20. Lack of long-term add-on effect by montelukast in postoperative chronic rhinosinusitis patients with nasal polyps.
    Van Gerven L, Langdon C, Cordero A, Cardelús S, Mullol J, Alobid I.
    Laryngoscope; 2018 Aug 01; 128(8):1743-1751. PubMed ID: 29114894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.